Business Segments · Goodwill
Diabetes Group — Goodwill
Medtronic Diabetes Group — Goodwill remained flat by 0.0% to $2.26B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.1%, from $2.25B to $2.26B. Over 4 years (FY 2021 to FY 2025), Diabetes Group — Goodwill shows relatively stable performance with a -0.0% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ2 2014
Last reportedQ1 2026
Rolls up toGoodwill
How to read this metric
A significant increase suggests recent acquisition activity, while a decrease may signal impairment charges due to poor segment performance.
Detailed definition
This represents the premium paid over the fair value of net identifiable assets when acquiring businesses within the dia...
Peer comparison
Standard accounting line item found in segment reporting for companies with active M&A strategies.
Metric ID:
mdt_segment_diabetes_goodwillHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.26B | $2.26B | $2.26B | $2.25B | $2.25B | $2.25B | $2.25B | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B | $2.26B | $2.25B | $2.26B | $2.26B | $2.26B | $2.26B |
| QoQ Change | — | -0.1% | +0.0% | -0.0% | +0.0% | -0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -0.1% | -0.1% | -0.0% | +0.0% | +0.0% | +0.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.0% | +0.0% | +0.0% | +0.0% | +0.1% |
Range$2.25B – $2.26B
CAGR-0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak4 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's diabetes group — goodwill?
- Medtronic (MDT) reported diabetes group — goodwill of $2.26B in Q1 2026.
- How has Medtronic's diabetes group — goodwill changed year-over-year?
- Medtronic's diabetes group — goodwill increased by 0.1% year-over-year, from $2.25B to $2.26B.
- What is the long-term trend for Medtronic's diabetes group — goodwill?
- Over 4 years (2021 to 2025), Medtronic's diabetes group — goodwill has grown at a -0.0% compound annual growth rate (CAGR), from $9.03B to $9.02B.
- What does diabetes group — goodwill mean?
- The intangible asset value recorded when the diabetes segment acquires other companies.